The protracted saga of listing migraine preventive drugs on the PBS has taken a new turn with the Pharmaceutical Benefits Advisory Committee now redefining the criteria it will use for migraine attacks. The PBAC has said it wants to abandon terms such as ‘chronic’ and ‘episodic’ migraine in PBS listing criteria and replace them with ...
New twist in bid for CGRP listings on PBS
By Michael Woodhead
23 Mar 2021